Insider Trading & SAST disclosures for GlaxoSmithKline Pharmaceuticals Ltd.
The latest disclosure under SEBI Prohibition of Insider Trading regulations was made by
Castleton Investment Ltd in GlaxoSmithKline Pharmaceuticals Ltd. where Disposal of 3,192,238
Equity Shares done at an average price of Rs. 2725
was reported to the exchange on March 30, 2017.
The latest disclosures under SEBI SAST(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 transaction was made by
Life Insurance Corporation of India in GlaxoSmithKline Pharmaceuticals Ltd. where Disposal of 3,463,785
shares done
was reported to the exchange on Sept. 14, 2022.
Insider trades are disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015 ([Regulation 7 (2) with 6(2)] made by corporate insiders: promoters, officers, directors, employees and large shareholders who are buying and selling stock in their own companies.
| Client Name |
Client Category |
Action* |
Reported To/By Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Period |
Regulation (Insider/SAST) |
Security Type |
Mode |
|
Life Insurance Corporation of India
|
Other |
Disposal |
21 Sep 2022 |
3,463,785 |
7,380,777
(4.35%)
|
2.04%
|
|
-
|
11 Sep 2018
13 Sep 2022 |
SAST (29(2)) |
- |
Market |
|
Life Insurance Corporation of India
|
Other |
Disposal |
20 Dec 2019 |
3,402,936 |
10,162,088
(5.99%)
|
2%
|
|
-
|
19 Dec 2012
19 Dec 2019 |
SAST (29(2)) |
- |
Market |
|
Castleton Investment Ltd
|
Promoter |
Disposal |
30 Mar 2017 |
3,192,238 |
-
|
1.88%
|
2725 |
8,698,848,550
|
30 Mar 2017
30 Mar 2017 |
Insider Trading |
Equity Shares |
Off Market / Inter se transfer |
|
GlaxoSmith Kline Pet Ltd
|
Promoter |
Acquisition |
30 Mar 2017 |
3,192,238 |
23,802,012
(28.10%)
|
1.88%
|
2725 |
8,698,848,550
|
30 Mar 2017
30 Mar 2017 |
Insider Trading |
Equity Shares |
Off Market / Inter se transfer |
|
GlaxoSmithKline Pte Ltd
|
Other |
Acquisition |
30 Mar 2017 |
3,192,238 |
-
|
3.77%
|
|
-
|
30 Mar 2017
30 Mar 2017 |
SAST (10(6)) |
- |
- |
|
GlaxoSmithKline Pte Ltd & Others
|
Promoter |
Acquisition |
30 Mar 2017 |
3,192,238 |
23,802,012
(28.10%)
|
3.77%
|
|
-
|
30 Mar 2017
30 Mar 2017 |
SAST (29(2)) |
- |
Off Market / Inter se transfer |
|
GlaxoSmithKline Pte Ltd and PACs
|
Promoter |
Disposal |
30 Mar 2017 |
3,192,238 |
-
|
3.77%
|
|
-
|
30 Mar 2017
30 Mar 2017 |
SAST (29(2)) |
- |
Off Market / Inter se transfer |
|
GlaxoSmithKline Pte Ltd (Revised)
|
Promoter |
Acquisition |
21 Mar 2017 |
3,192,238 |
-
|
3.77%
|
|
-
|
30 Mar 2017
30 Mar 2017 |
SAST (10(1)(a)) |
- |
None |
|
Aberdeen Asset Management Asia Ltd
|
Other |
Disposal |
24 Mar 2014 |
12,636,245 |
1,312,075
(1.54%)
|
14.91%
|
|
-
|
20 Mar 2014
20 Mar 2014 |
SAST (29(2)) |
- |
Market |
|
GlaxoSmithKline Pte Ltd
|
Promoter |
Acquisition |
12 Mar 2014 |
20,609,774 |
20,609,774
(24.33%)
|
24.33%
|
|
-
|
10 Mar 2014
10 Mar 2014 |
SAST (29(1)) |
- |
Open Offer |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.